Will avelumab plus cabozatinib outperform avelumab monotherapy as maintenance treatment?
In search of improved outcomes for patients
A new standard treatment option for advanced/metastatic cases
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy